February 3, 2022 07:21 AM EST
People
Pharma

Cod­ed cal­en­dar in­vites, covert emails and delet­ed doc­u­ments: Pfiz­er sues ex-em­ploy­ees for al­leged­ly steal­ing trade se­crets

Amber Tong

When Re­gor Ther­a­peu­tics un­veiled a col­lab­o­ra­tion back in De­cem­ber with Eli Lil­ly to dis­cov­er and de­vel­op new drugs for meta­bol­ic dis­or­ders, founder and CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

Ax­some moves to­ward NDA fil­ing for nar­colep­sy drug fol­low­ing pos­i­tive Phase 3 da­ta

A service from the Financial Times